1. Home
  2. News
  3. Lumos Diagnostics Holdings Ltd.
  4. FebriDx Paediatric Study Enrolment Milestone Achieved
More Lumos Diagnostics Holdings Ltd. news
Lumos Diagnostics Holdings Ltd.ASX: LDX

FebriDx Paediatric Study Enrolment Milestone Achieved

May 13, 2026 at 11:57 PM EDT · Issued by Lumos Diagnostics Holdings Ltd.

Filed with ASX · May 13, 2026 at 11:57 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/febridx-paediatric-study-enrolment-milestone-achieved

Watch Lumos Diagnostics' latest call↗Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call↗

Lumos Diagnostics Holdings Ltd. on 6ix

Story so far

  • Lumos Completes Enrolment Milestone for Paediatric StudyFeb 23, 2026
  • LDX & BARDA partner on new US$6.2m FebriDx Paediatric StudySep 1, 2025

Earlier from Lumos Diagnostics

  • Response to ASX Aware LetterApr 10
  • ProspectusApr 9
  • Lumos secures new contract manufacturing agreementApr 8
  • Lumos receives largest FebriDx order to dateApr 1
  • Investor PresentationMar 26

Later from Lumos Diagnostics

  • FebriDx U.S. Rollout and Reimbursement UpdateMay 17
  • FebriDx U.S. Rollout and Reimbursement Update - AmendedMay 18
  • FebriDx Commercial Traction Across Priority US AccountsJul 20
  • Lumos Receives FebriDx Order from PHASE ScientificAug 3
  • FY26 Appendix 4EAug 25
All Lumos Diagnostics news releases↗

Follow Lumos Diagnostics into a list and get an email when it puts out news.

Follow Lumos Diagnostics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer